Article 46 work-sharing

  • Covaxis (Triaxis/Adacel) (diphtheria, tetanus, pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content))

    DE/W/0034/pdWS/003
    End of Procedure: 15/01/2014
    Date of Publication: 06/05/2014

    DE/W/0034/pdWS/004
    End of Procedure: 07/02/2016
    Date of Publication: 07/04/2016
  • Daivobet (calcipotriol/bethamethasone)

    DK/W/0027/pdWS/001
    End of Procedure: 06/02/2013
    Date of Publication: 02/04/2013

    DK/W/0027/pdWS/002
    End of Procedure: 26/03/2014
    Date of Publication: 03/06/2014
  • Engerix B
    End of Procedure: 22/02/2012
    Date of Publication: 02/07/2012
  • Famvir and associated names (famciclovir)

    DE/W/005/pdWS/001
    End of Procedure: 26/05/2010
    Date of Publication: 05/08/2010

    DE/W/005/pdWS/002
    End of Procedure: 08/06/2011
    Date of Publication: 06/07/2011
  • Favirab
    End of Procedure:30/12/2011
    Date of Publication: 28/09/2012
  • Gadopentetate
    End of Procedure: 03/02/2014
    Date of Publication: 01/04/2014
  • Genotropin and associated names (somatropin)

    DK/W/008/pdWS/001
    End of Procedure: 06/10/2010
    Date of Publication: 24/10/2010

    DK/W/008/pdWS/002
    End of Procedure: 16/03/2011
    Date of Publication: 24/11/2010
    Update: 27/04/2011

    DK/W/008/pdWS/003
    End of Procedure: 27/11/2012
    Date of Publication: 24/01/2013

    DK/W/008/pdWS/004
    End of Procedure: 09/10/2013
    Date of Publication: 02/12/2013
  • Humatrope
    End of Procedure: 17/09/2009
    Date of Publication: 04/06/2012
  • Imovax Polio
    End of Procedure: 18/04/2011
    Date of Publication: 28/09/2012
  • Menitorix (haemophilus influenzae type b conjugate, neisseria meningitidis capsular polysaccharide  C, Tetanus toxoid conjugates)

      UK/W/028/pdWS/001
      End of Procedure: 21/03/2012
      Date of Publication: 31/10/2013

      UK/W/028/pdWS/002
      End of Procedure: 14/06/2012
      Date of Publication: 31/10/2013

      UK/W/028/pdWS/003
      End of Procedure: 20/03/2013
      Date of Publication: 31/10/2013

      UK/W/028/pdWS/004
      End of Procedure: 17/06/2013
      Date of Publication: 31/10/2013

      UK/W/028/pdWS/005
      End of Procedure:30/09/2013
      Date of Publication: 09/10/2014
  
      UK/W/028/pdWS/006
      End of Procedure: 12/06/2014
      Date of Publication: 04/08/2014

  • Neurontin (gabapentin)

    DE/W/041/pdWS/001
    End of Procedure: 17/06/2011
    Date of Publication: 08/08/2011

    DE/W/041/pdWS/002
    End of procedure: 14/12/2015
    Date of publication: 09/02/2016

  • Palexia and associated names (tapentadol hydrochloride)

    DE/W/083/pdWS/001
    End of Procedure: 01/07/2014
    Date of Publication: 09/10/2014

    DE/W/083/pdWS/002
    End of Procedure: 15/12/2014
    Date of Publication: 30/01/2015

  • Pentavac/Pentaxim (Haemophilus type b vaccine)

    SE/W/0015/pdWS/001
    End of Procedure: 19/12/2013
    Date of Publication: 04/03/2014

    SE/W/0015/0015/002
    End of Procedure: 17/04/2015
    Date of Publication: 06/07/2015
  • Poliorix
    End of Procedure: 03/09/2012
    Date of Publication: 06/03/2013
  • Seretide Diskus/ Seretide Eudraler and associated names (salmeterol xinafoate/fluticasone propionate)
      
    SE/W/005/pdWS/001
    End of Procedure: 12/01/2009
    Date of Publication: 05/01/2011
     
    SE/W/005/pdWS/002
    End of Procedure: 18/03/2013
    Date of Publication: 20/06/2013 
     
    SE/W/005/pdWS/003
    End of procedure: 13/01/2015
    Date of publication: 01/04/2015
  • Seroquel (quetapine)

    NL/W/004/pdWS/001
    End of Procedure: 07/12/2009
    Date of Publication: 26/09/2013
     
    NL/W/004/pdWS/002
    End of Procedure: 17/12/2012
    Date of Publication: 26/09/2013